Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  BG Medicine, Inc.    BGMD   US08861T1079

BG MEDICINE, INC. (BGMD)

11
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

BG MEDICINE : Other Events, Financial Statements and Exhibits (form 8-K)

07/06/2015 | 08:14am US/Eastern

Item 8.01. Other Events.

On July 6, 2015, BG Medicine, Inc. (the "Company"), issued a press release in which it announced that the ARCHITECT® Galectin-3 assay is now available in the United States. This automated blood test was cleared by the FDA for use in conjunction with clinical evaluation as an aid in assessing the prognosis of patients diagnosed with chronic heart failure. This is the first automated test for galectin-3 to be introduced for commercial use in the United States. The Company is the developer of the BGM Galectin-3® Test, which is the FDA-cleared manual microtiter plate method for testing for galectin-3, and the licensor of the automated galectin-3 assay. The ARCHITECT® galectin-3 assay is performed using the Abbott ARCHITECT® automated immunoassay analyzer and is being commercialized through an agreement between the Company and Abbott. A copy of the press release issued by the Company is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) The following exhibits are filed with this report:




       Exhibit   Description

       99.1      Press Release of BG Medicine, Inc. issued on July 6, 2015.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

React to this article
Latest news on BG MEDICINE, INC.
08:14a BG MEDICINE : Other Events, Financial Statements and Exhibits (form 8-K)
08:01a First Automated Test for Galectin-3 Now Available in U.S.
07:14a BG MEDICINE : Other Events (form 8-K)
06/09 BG MEDICINE : Entry into a Material Definitive Agreement, Creation of a Direct F..
05/15 BG MEDICINE : Reports First Quarter 2015 Financial Results
05/14 BG MEDICINE : Results of Operations and Financial Condition, Other Events, Finan..
05/14 BG Medicine Reports First Quarter 2015 Financial Results
05/14 BG MEDICINE : Reports First Quarter 2015 Financial Results
05/12 BG MEDICINE : Entry into a Material Definitive Agreement, Creation of a Direct F..
05/08 BG MEDICINE : Announces Q1 2015 Financial Results Release Date and Conference Ca..
Advertisement
Chart
Duration : Period :
BG Medicine, Inc. Technical Analysis Chart | BGMD | US08861T1079 | 4-Traders
Income Statement Evolution
More Financials